InsidersTradesSigma
Follow the 제넥신 share price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares are listed on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 제넥신 has logged 1 public disclosures. Market capitalisation: €109.8bn. The latest transaction was filed on 11 March 2026 (Other). Among the most active insiders: 제넥신. The full history is free.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Genexine 是一家生物技术公司，专注于开发用于治疗自身免疫疾病和癌症的创新药物。该公司在 XKRX 市场上市。